Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Personalized Medicine Industry?

Over the past few years, the size of the personalized medicine market has expanded significantly. The market, which stood at $386.27 billion in 2024, is projected to increase to $422.9 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.5%. The historical growth trends in this market can be linked to the emergence of companion diagnostics, the focus on patient-centric healthcare, a shift in the paradigm of drug development, efforts to contain healthcare costs, and the rising incidence of chronic diseases.

The market for personalized medicine is predicted to expand considerably in the coming years, growing to “$650.59 billion in 2029 with a compound annual growth rate (CAGR) of 11.4%.” This surge in the predicted period can be credited to ongoing advances in genomics, the broadening of biomarker identification, the rising use of telemedicine, supportive regulatory frameworks, and collaboration and information sharing. The forecast period will witness major trends such as the incorporation of artificial intelligence (AI), progress in genomic sequencing, data amalgamation and analysis, immunotherapy and specific therapies, the enhancement of patient authority and educated decision-making, and collaborations and alliances.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp

What Forces Are Driving The Growth Of The Personalized Medicine Industry?

The uptick in rare diseases is anticipated to fuel the expansion of the personalized medicine market. This surge corresponds to an increasing count of individuals identified with conditions such as Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Personalized medicine offers bespoke treatment strategies, catering to the exclusive needs of patients with rare diseases. To illustrate, the Genetic Alliance UK, a national charity based in the UK dedicated to helping those affected by genetic, rare and undiagnosed conditions, reported in February 2024 that 3.5 million people in the UK are living with a rare disease and 1 in 17 individuals will at some stage in their life be impacted by a rare condition. Hence, as the escalated prevalence of rare diseases persists, it is fostering the growth of the personalized medicine market.

The personalized medicine market covered in this report is segmented –

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness

2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications

3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users

Subsegments:

1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging

2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products

3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring

4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs

What Trends Are Currently Influencing Growth In The Personalized Medicine Market?

Advancements in technology are emerging as a dominant trend in the personalized medicine sector. The implementation of novel technologies is being leveraged by leading companies in the personalized medicine market to maintain their market position. For instance, OM1, a healthcare firm based in the US that uses real-world data and artificial intelligence (AI) to support healthcare providers, registered a patent for an AI-driven platform in April 2023 to promote personalized medicine. This innovation makes use of wide-scale data analysis to draw valuable conclusions about diagnoses, disease progression, and treatment responses. It is particularly valuable because it provides customized healthcare information, improves healthcare providers’ decision-making process, and speeds up clinical trials by efficiently identifying suitable candidates, leading to the further progression of personalized medicine in the market.

Who Are The Primary Players Operating Across The Global Personalized Medicine Market?

Major companies operating in the personalized medicine market include Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

Which Region Offers The Most Growth Potential For The Personalized Medicine Market Through 2029?

North America was the largest region in the personalized medicine market in 2024. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10272&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model